Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease (Q37982645)

26 August 2017

Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

3

Paul Muntner

1 reference

26 August 2017

Rikki M Tanner

1

1 reference

PubMed ID

22318504

26 August 2017

Todd M Brown

series ordinal

2

1 reference

26 August 2017

1 April 2012

1 reference

Current Hypertension Reports

26 August 2017

1 reference

26 August 2017

14

1 reference

26 August 2017

2

1 reference

26 August 2017

152-159

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-012-0254-y

26 August 2017

0 references

cites work

Prevalence and trends in obesity among US adults, 1999-2008

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Global burden of obesity in 2005 and projections to 2030.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Annual Deaths Attributable to Obesity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

The disease burden associated with overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

The public health impact of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Prevalence and Trends in Obesity Among US Adults, 1999-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Prevalence of the metabolic syndrome and overweight among adults in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Increasing prevalence of the metabolic syndrome among u.s. Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Can body mass index, waist circumference, waist-hip ratio and waist-height ratio predict the presence of multiple metabolic risk factors in Chinese subjects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Overweight, obesity, and elevated serum cystatin C levels in adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Metabolic syndrome and kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Body mass index and risk for end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

A population-based, prospective study of blood pressure and risk for end-stage renal disease in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Weight loss in obese patients with chronic kidney disease: who and how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Obesity management in adults with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Clinical practice. Nonsurgical management of obesity in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

End-stage renal disease in African-American and white men. 16-year MRFIT findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Effect of blood pressure on early decline in kidney function among hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Guidelines for the management of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

The metabolic syndrome and chronic kidney disease in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Effect of lipid reduction on the progression of renal disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Role of oxidative stress in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0254-Y

Early predictors of 15-year end-stage renal disease in hypertensive patients

21 January 2018

1 reference

12 December 2020

Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure

1 reference

12 December 2020

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

1 reference

12 December 2020

History of hypertension in patients treated for end-stage renal disease

1 reference

12 December 2020

Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines.

1 reference

12 December 2020

Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy

1 reference

12 December 2020

Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN)

1 reference

12 December 2020

Increasing Body Mass Index and Obesity in the Incident ESRD Population

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11906-012-0254-Y

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22318504